The Motley FoolFri, 20 Mar 2026 17:49:23 GMTThis $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This YearVERA-1.63%
Seeking AlphaFri, 06 Mar 2026 20:05:54 GMTVera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference TranscriptVERA-1.63%
Seeking AlphaFri, 20 Feb 2026 21:00:27 GMTVera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)VERA-1.63%
